In order to maximize the predictive power of these immune-associated genes, we extended the survival analysis P value threshold to 0.1 and thereafter identified four genes for use as an IMOPP of HCC: CCL14, KLKB1, VIPR1, and CD4. The gene discussed is CD4; the disease is hepatocellular carcinoma.